Clinical Trials on Cartilage Damage in Luxembourg

Total 1 results

Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents (RECLAIM-DCP)

Cerebral Palsy, Dyskinetic

United States, Denmark, Israel, Italy, Poland, Russian Federation, Spain, Ukraine, United Kingdom, Canada, Slovakia, Belgium

3

Subscribe